Levy Richard S
Insider CIK 1454983 · MDGL Director · TARA Director · CNST Director · KOD Director · KNSA Director · INCY EVP, Chief Drug Dev&Medical Of
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-08-01 | 2026-08-04 | 403 | — | $0 | 403 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-08-01 | 2026-08-04 | 403 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-08-01 | 2026-08-04 | 403 | — | $0 | 22,359 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-08-01 | 2026-08-04 | 403 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-08-01 | 2026-08-04 | 403 | — | $0 | 403 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-08-01 | 2026-08-04 | 403 | — | — | 22,359 | SEC↗ |
| KOD Kodiak Sciences Inc. | A Award deriv | 2026-06-30 | 2026-07-02 | 17,731 | — | $0 | 17,731 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2026-06-17 | 2026-06-18 | 766 | — | $0 | 766 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2026-06-17 | 2026-06-18 | 454 | — | $0 | 22,469 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2026-06-15 | 2026-06-16 | 31,000 | — | $0 | 31,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-05-29 | 2026-06-02 | 2,026 | — | $0 | 2,026 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-05-29 | 2026-06-02 | 12,158 | — | $0 | 12,158 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 21,956 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-22 | 2026-05-22 | 320 | $508.24 | $162.6K | 27,337 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-22 | 2026-05-22 | 40 | $506.68 | $20.3K | 27,657 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-22 | 2026-05-22 | 151 | $510.36 | $77.1K | 27,186 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-22 | 2026-05-22 | 610 | $511.40 | $312.0K | 26,576 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-22 | 2026-05-22 | 439 | $512.50 | $225.0K | 26,137 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-22 | 2026-05-22 | 40 | $512.97 | $20.5K | 26,097 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-22 | 2026-05-22 | 343 | $514.67 | $176.5K | 25,754 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-22 | 2026-05-22 | 657 | $515.92 | $339.0K | 25,097 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-22 | 2026-05-22 | 723 | $516.87 | $373.7K | 24,374 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-22 | 2026-05-22 | 1,497 | $517.59 | $774.8K | 22,877 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-22 | 2026-05-22 | 782 | $518.76 | $405.7K | 22,095 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-05-22 | 2026-05-22 | 80 | $519.98 | $41.6K | 22,015 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2026-02-23 | 2026-02-24 | 2,500 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2026-02-23 | 2026-02-24 | 2,500 | $7.36 | $18.4K | 27,697 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-02-01 | 2026-02-04 | 683 | — | $0 | 683 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-02-01 | 2026-02-04 | 683 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-02-01 | 2026-02-04 | 683 | — | $0 | 19,157 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2026-01-26 | 2026-01-26 | 4,000 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2026-01-26 | 2026-01-26 | 4,000 | $16.46 | $65.8K | 25,197 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-11-13 | 2025-11-14 | 2,500 | — | $0 | 2,500 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-11-13 | 2025-11-14 | 6,000 | — | $0 | 4,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-11-13 | 2025-11-14 | 6,000 | $16.46 | $98.8K | 29,697 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-11-13 | 2025-11-14 | 2,500 | $7.36 | $18.4K | 23,697 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 40 | $530.21 | $21.2K | 21,197 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 440 | $528.60 | $232.6K | 21,237 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 200 | $527.85 | $105.6K | 21,677 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 120 | $526.68 | $63.2K | 21,877 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 153 | $524.49 | $80.2K | 21,997 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 811 | $523.66 | $424.7K | 22,150 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 1,434 | $522.70 | $749.6K | 22,961 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 1,094 | $521.79 | $570.8K | 24,395 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 308 | $520.68 | $160.4K | 25,489 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 1,355 | $519.67 | $704.2K | 25,797 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 835 | $518.53 | $433.0K | 27,152 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 645 | $517.51 | $333.8K | 27,987 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 919 | $515.64 | $473.9K | 28,632 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-11-13 | 2025-11-14 | 146 | $514.67 | $75.1K | 29,551 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-07-01 | 2025-07-03 | 1,101 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-07-01 | 2025-07-03 | 1,101 | — | $0 | 1,101 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-07-01 | 2025-07-03 | 1,101 | — | $0 | 18,474 | SEC↗ |
| KOD Kodiak Sciences Inc. | A Award deriv | 2025-06-30 | 2025-07-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2025-06-20 | 2025-06-24 | 1,290 | — | $0 | 1,290 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2025-06-20 | 2025-06-24 | 715 | — | $0 | 21,197 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-05 | 2025-06-05 | 3,173 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-05 | 2025-06-05 | 3,173 | — | $0 | 17,373 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-06-03 | 2025-06-05 | 16,798 | — | $0 | 16,798 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-06-03 | 2025-06-05 | 2,799 | — | $0 | 2,799 | SEC↗ |
| TARA Protara Therapeutics, Inc. | P Buy | 2025-05-14 | 2025-05-16 | 20,000 | $3.19 | $63.8K | 51,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | P Buy | 2025-05-14 | 2025-05-19 | 20,000 | $3.19 | $63.8K | 51,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-04-10 | 2025-04-11 | 9,470 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-04-10 | 2025-04-11 | 9,470 | $65.06 | $616.1K | 20,482 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-11-07 | 2024-11-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2024-11-07 | 2024-11-12 | 1,303 | — | $0 | 1,303 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2024-11-07 | 2024-11-12 | 1,303 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-11-07 | 2024-11-08 | 5,000 | $350.00 | $1.75M | 11,012 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-11-07 | 2024-11-08 | 5,000 | $7.36 | $36.8K | 16,012 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2024-11-07 | 2024-11-12 | 1,303 | — | $0 | 14,200 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-11-01 | 2024-11-05 | 5,000 | — | $0 | 10,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-11-01 | 2024-11-05 | 300 | $304.29 | $91.3K | 11,012 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-11-01 | 2024-11-05 | 5,000 | $7.36 | $36.8K | 16,012 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-11-01 | 2024-11-05 | 2,800 | $300.10 | $840.3K | 13,212 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-11-01 | 2024-11-05 | 1,100 | $301.22 | $331.3K | 12,112 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-11-01 | 2024-11-05 | 800 | $302.25 | $241.8K | 11,312 | SEC↗ |
| KOD Kodiak Sciences Inc. | A Award deriv | 2024-06-28 | 2024-07-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2024-06-25 | 2024-06-27 | 1,105 | — | $0 | 1,105 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2024-06-25 | 2024-06-27 | 714 | — | $0 | 11,012 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2024-06-07 | 2024-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-06-06 | 2024-06-07 | 4,373 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-06-06 | 2024-06-07 | 4,373 | — | $0 | 12,897 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-06-05 | 2024-06-07 | 3,173 | — | $0 | 3,173 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-06-05 | 2024-06-07 | 19,040 | — | $0 | 19,040 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-05-03 | 2024-05-07 | 747 | — | $0 | 747 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-05-03 | 2024-05-07 | 747 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-05-03 | 2024-05-07 | 747 | — | $0 | 8,524 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-01 | 2024-04-03 | 6,000 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-01 | 2024-04-03 | 5,000 | — | $0 | 15,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 300 | $267.07 | $80.1K | 10,298 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 1,600 | $257.93 | $412.7K | 11,411 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 100 | $259.07 | $25.9K | 11,311 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 713 | $265.28 | $189.1K | 10,598 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 3,900 | $256.88 | $1.00M | 13,011 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-01 | 2024-04-03 | 4,387 | $255.90 | $1.12M | 16,911 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-01 | 2024-04-03 | 6,000 | $111.06 | $666.4K | 21,298 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-01 | 2024-04-03 | 5,000 | $7.36 | $36.8K | 15,298 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-11-03 | 2023-11-07 | 2,777 | — | $0 | 2,777 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-11-03 | 2023-11-07 | 2,777 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-11-03 | 2023-11-07 | 2,777 | — | $0 | 7,777 | SEC↗ |
| KOD Kodiak Sciences Inc. | A Award deriv | 2023-06-30 | 2023-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-06-29 | 2023-07-03 | 5,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-06-29 | 2023-07-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2023-06-15 | 2023-06-20 | 1,198 | — | $0 | 10,298 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-06-06 | 2023-06-08 | 4,373 | — | $0 | 4,373 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-06-06 | 2023-06-08 | 26,236 | — | $0 | 26,236 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2023-01-17 | 2023-01-19 | 10,000 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2023-01-17 | 2023-01-19 | 12,489 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2023-01-17 | 2023-01-19 | 12,489 | $105.08 | $1.31M | 21,589 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-01-17 | 2023-01-19 | 100 | $285.28 | $28.5K | 31,489 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-01-17 | 2023-01-19 | 400 | $287.08 | $114.8K | 31,089 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-01-17 | 2023-01-19 | 300 | $288.91 | $86.7K | 30,789 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-01-17 | 2023-01-19 | 1,600 | $290.36 | $464.6K | 29,189 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-01-17 | 2023-01-19 | 3,325 | $291.66 | $969.8K | 25,864 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-01-17 | 2023-01-19 | 5,227 | $292.68 | $1.53M | 20,637 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-01-17 | 2023-01-19 | 3,548 | $293.54 | $1.04M | 17,089 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-01-17 | 2023-01-19 | 5,164 | $294.68 | $1.52M | 11,925 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-01-17 | 2023-01-19 | 2,325 | $295.45 | $686.9K | 9,600 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2023-01-17 | 2023-01-19 | 500 | $296.68 | $148.3K | 9,100 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2023-01-17 | 2023-01-19 | 10,000 | $100.45 | $1.00M | 31,589 | SEC↗ |
| KOD Kodiak Sciences Inc. | A Award deriv | 2022-06-30 | 2022-07-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-06-29 | 2022-06-30 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-06-29 | 2022-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2022-06-16 | 2022-06-21 | 9,470 | — | $0 | 9,470 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 13,171 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 26,342 | — | $0 | 0 | SEC↗ |
| KOD Kodiak Sciences Inc. | A Award deriv | 2021-06-30 | 2021-07-02 | 7,368 | — | $0 | 7,368 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-06-29 | 2021-06-30 | 33,237 | — | $0 | 33,237 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2021-06-17 | 2021-06-21 | 12,489 | — | $0 | 12,489 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2021-06-09 | 2021-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2021-06-02 | 2021-06-04 | 13,171 | — | $0 | 13,171 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2020-06-30 | 2020-07-02 | 18,760 | — | $0 | 18,760 | SEC↗ |
| KOD Kodiak Sciences Inc. | A Award deriv | 2020-06-30 | 2020-07-02 | 7,106 | — | $0 | 7,106 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2020-06-17 | 2020-06-18 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 9,000 | — | $0 | 9,000 | SEC↗ |
| KOD Kodiak Sciences Inc. | A Award deriv | 2020-06-08 | 2020-06-10 | 4,135 | — | $0 | 4,135 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2020-04-03 | 2020-04-06 | 26,342 | — | $0 | 26,342 | SEC↗ |
| KOD Kodiak Sciences Inc. | P Buy | 2020-03-20 | 2020-03-24 | 250 | $43.37 | $10.8K | 250 | SEC↗ |
| KOD Kodiak Sciences Inc. | P Buy | 2020-03-20 | 2020-03-24 | 750 | $44.65 | $33.5K | 1,000 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award | 2020-01-10 | 2020-01-13 | 31,000 | — | $0 | 31,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2019-06-27 | 2019-07-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KOD Kodiak Sciences Inc. | A Award deriv | 2019-06-03 | 2019-06-05 | 24,747 | — | $0 | 24,747 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2019-03-04 | 2019-03-06 | 37,965 | — | $0 | 37,965 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2018-06-19 | 2018-06-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-23 | 2017-08-24 | 7 | $16.25 | $114 | 9,100 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-23 | 2017-08-24 | 1,793 | $16.12 | $28.9K | 9,093 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-23 | 2017-08-24 | 100 | $16.08 | $1.6K | 7,200 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-23 | 2017-08-24 | 100 | $16.11 | $1.6K | 7,300 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-22 | 2017-08-23 | 127 | $16.14 | $2.0K | 7,100 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-22 | 2017-08-23 | 2,944 | $16.12 | $47.5K | 6,973 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-22 | 2017-08-23 | 389 | $16.10 | $6.3K | 4,029 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-22 | 2017-08-23 | 90 | $15.99 | $1.4K | 3,640 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-21 | 2017-08-22 | 200 | $16.02 | $3.2K | 2,310 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-21 | 2017-08-22 | 100 | $15.72 | $1.6K | 1,100 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-21 | 2017-08-22 | 900 | $15.67 | $14.1K | 900 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-21 | 2017-08-22 | 590 | $16.09 | $9.5K | 3,550 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-21 | 2017-08-22 | 440 | $16.07 | $7.1K | 2,960 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-21 | 2017-08-22 | 210 | $16.04 | $3.4K | 2,520 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-21 | 2017-08-22 | 100 | $15.70 | $1.6K | 1,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-21 | 2017-08-22 | 200 | $15.93 | $3.2K | 2,110 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-21 | 2017-08-22 | 10 | $15.90 | $159 | 1,910 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-21 | 2017-08-22 | 400 | $15.80 | $6.3K | 1,900 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-21 | 2017-08-22 | 200 | $15.79 | $3.2K | 1,500 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2017-08-21 | 2017-08-22 | 200 | $15.77 | $3.2K | 1,300 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2017-06-29 | 2017-06-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2016-08-11 | 2016-11-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2016-01-06 | 2016-01-08 | 3,937 | — | $0 | 2,876 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2016-01-06 | 2016-01-08 | 3,937 | $18.32 | $72.1K | 20,863 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2016-01-06 | 2016-01-08 | 3,937 | $101.86 | $401.0K | 16,926 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-12-07 | 2015-12-09 | 3,937 | — | $0 | 6,813 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-12-07 | 2015-12-09 | 3,937 | $18.32 | $72.1K | 20,863 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-12-07 | 2015-12-09 | 3,937 | $106.18 | $418.0K | 16,926 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-11-06 | 2015-11-10 | 3,936 | — | $0 | 10,750 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-11-06 | 2015-11-10 | 3,936 | $116.51 | $458.6K | 16,926 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-11-06 | 2015-11-10 | 3,936 | $18.32 | $72.1K | 20,862 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-10-06 | 2015-10-08 | 3,937 | — | $0 | 14,686 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-10-06 | 2015-10-08 | 3,937 | $122.29 | $481.5K | 16,926 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-10-06 | 2015-10-08 | 3,937 | $18.32 | $72.1K | 20,863 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-09-11 | 2015-09-15 | 4,301 | $130.00 | $559.1K | 16,926 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-09-08 | 2015-09-10 | 3,937 | — | $0 | 18,623 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-09-08 | 2015-09-10 | 3,937 | $118.90 | $468.1K | 21,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-09-08 | 2015-09-10 | 3,937 | $18.32 | $72.1K | 25,164 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-08-06 | 2015-08-10 | 3,936 | — | $0 | 22,560 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-08-06 | 2015-08-10 | 3,936 | $111.95 | $440.6K | 21,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-08-06 | 2015-08-10 | 3,936 | $18.32 | $72.1K | 25,163 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-07-15 | 2015-07-16 | 70,217 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-07-15 | 2015-07-16 | 70,217 | $120.00 | $8.43M | 21,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-07-15 | 2015-07-16 | 70,217 | $17.79 | $1.25M | 91,444 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-07-06 | 2015-07-08 | 3,937 | — | $0 | 26,496 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-07-06 | 2015-07-08 | 3,937 | $107.00 | $421.3K | 21,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-07-06 | 2015-07-08 | 3,937 | $18.32 | $72.1K | 25,164 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-06-19 | 2015-06-23 | 20,000 | — | $0 | 70,217 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-06-19 | 2015-06-23 | 20,000 | $108.13 | $2.16M | 21,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-06-19 | 2015-06-23 | 20,000 | $17.79 | $355.8K | 41,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-06-08 | 2015-06-10 | 3,937 | — | $0 | 30,433 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-06-08 | 2015-06-10 | 3,937 | $18.32 | $72.1K | 25,164 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-06-08 | 2015-06-10 | 3,937 | $107.58 | $423.5K | 21,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-05-06 | 2015-05-08 | 7,412 | — | $0 | 34,370 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-05-06 | 2015-05-08 | 7,412 | $18.32 | $135.8K | 28,639 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-06 | 2015-05-08 | 7,412 | $99.43 | $737.0K | 21,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-04-06 | 2015-04-08 | 25,000 | — | $0 | 41,782 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-04-06 | 2015-04-08 | 25,000 | $88.77 | $2.22M | 21,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-04-06 | 2015-04-08 | 25,000 | $18.32 | $458.0K | 46,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-03-06 | 2015-03-10 | 25,000 | — | $0 | 66,782 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-03-06 | 2015-03-10 | 25,000 | $89.91 | $2.25M | 21,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-03-06 | 2015-03-10 | 25,000 | $18.32 | $458.0K | 46,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-02-17 | 2015-02-18 | 8,317 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-02-17 | 2015-02-18 | 3,683 | — | $0 | 90,217 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-02-17 | 2015-02-18 | 12,000 | $76.90 | $922.8K | 18,205 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-02-17 | 2015-02-18 | 8,317 | $14.72 | $122.4K | 30,205 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-02-17 | 2015-02-18 | 3,683 | $17.79 | $65.5K | 21,888 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-02-06 | 2015-02-10 | 25,000 | — | $0 | 91,782 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-02-06 | 2015-02-10 | 25,000 | $75.11 | $1.88M | 18,205 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-02-06 | 2015-02-10 | 25,000 | $18.32 | $458.0K | 43,205 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-01-16 | 2015-01-20 | 12,000 | — | $0 | 8,317 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-01-16 | 2015-01-20 | 12,000 | $73.07 | $876.8K | 18,205 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-01-16 | 2015-01-20 | 12,000 | $14.72 | $176.6K | 30,205 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-01-08 | 2015-01-09 | 1,085 | — | $0 | 1,085 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-01-08 | 2015-01-09 | 20,460 | — | $0 | 20,460 | SEC↗ |
| INCY INCYTE CORP | A Award | 2015-01-08 | 2015-01-09 | 3,022 | — | $0 | 21,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-01-06 | 2015-01-08 | 25,000 | — | $0 | 116,782 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-01-06 | 2015-01-08 | 25,000 | $18.32 | $458.0K | 43,205 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-01-06 | 2015-01-08 | 25,000 | $71.84 | $1.80M | 18,205 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-12-16 | 2014-12-18 | 12,000 | — | $0 | 20,317 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-12-16 | 2014-12-18 | 12,000 | $14.72 | $176.6K | 30,205 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-12-16 | 2014-12-18 | 12,000 | $72.36 | $868.3K | 18,205 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-11-17 | 2014-11-19 | 12,000 | — | $0 | 32,317 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-11-17 | 2014-11-19 | 12,000 | $14.72 | $176.6K | 30,205 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-11-17 | 2014-11-19 | 12,000 | $69.97 | $839.6K | 18,205 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-10-23 | 2014-10-24 | 13,904 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-10-23 | 2014-10-24 | 13,904 | $3.11 | $43.2K | 18,205 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-10-16 | 2014-10-20 | 8,000 | — | $0 | 44,317 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-10-16 | 2014-10-20 | 8,000 | $49.03 | $392.2K | 4,301 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-10-16 | 2014-10-20 | 8,000 | $14.72 | $117.8K | 12,301 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-09-16 | 2014-09-18 | 8,000 | — | $0 | 52,317 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-09-16 | 2014-09-18 | 8,000 | $14.72 | $117.8K | 12,301 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-09-16 | 2014-09-18 | 8,000 | $47.58 | $380.6K | 4,301 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-08-18 | 2014-08-19 | 8,000 | — | $0 | 60,317 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-08-18 | 2014-08-19 | 8,000 | $51.97 | $415.8K | 4,301 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-08-18 | 2014-08-19 | 8,000 | $14.72 | $117.8K | 12,301 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-07-16 | 2014-07-18 | 8,000 | — | $0 | 68,317 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-07-16 | 2014-07-18 | 8,000 | $14.72 | $117.8K | 12,301 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-07-16 | 2014-07-18 | 8,000 | $48.15 | $385.2K | 4,301 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-06-16 | 2014-06-18 | 8,000 | — | $0 | 76,317 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-06-16 | 2014-06-18 | 8,000 | $14.72 | $117.8K | 12,301 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-06-16 | 2014-06-18 | 8,000 | $53.88 | $431.0K | 4,301 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-05-16 | 2014-05-20 | 8,000 | — | $0 | 84,317 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-05-16 | 2014-05-20 | 8,000 | $50.68 | $405.4K | 4,301 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-05-16 | 2014-05-20 | 8,000 | $14.72 | $117.8K | 12,301 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-14 | 2014-02-18 | 24,787 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-14 | 2014-02-18 | 417 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-14 | 2014-02-18 | 14,583 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-14 | 2014-02-18 | 24,787 | $9.41 | $233.2K | 29,088 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-14 | 2014-02-18 | 14,583 | $13.34 | $194.5K | 43,671 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-14 | 2014-02-18 | 417 | $13.34 | $5.6K | 44,088 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-02-14 | 2014-02-18 | 39,787 | $66.13 | $2.63M | 4,301 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 1,945 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 33,055 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 25,862 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 47,913 | — | $0 | 24,787 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 61,096 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 9,138 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-13 | 2014-02-18 | 12,300 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 9,138 | $11.98 | $109.5K | 193,665 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 12,300 | $9.41 | $115.7K | 184,527 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 25,862 | $11.98 | $309.8K | 172,227 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 47,913 | $9.41 | $450.9K | 146,365 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 61,096 | $3.11 | $190.0K | 98,452 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 1,945 | $11.98 | $23.3K | 195,610 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-02-13 | 2014-02-18 | 191,309 | $66.38 | $12.70M | 4,301 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-13 | 2014-02-18 | 33,055 | $11.98 | $396.0K | 37,356 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2014-01-21 | 2014-01-23 | 997 | — | $0 | 997 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2014-01-21 | 2014-01-23 | 34,868 | — | $0 | 34,868 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-09-06 | 2013-09-09 | 25,000 | — | $0 | 862 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2013-09-06 | 2013-09-09 | 25,000 | $35.28 | $882.0K | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-09-06 | 2013-09-09 | 25,000 | $11.98 | $299.5K | 25,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-05-13 | 2013-05-15 | 4,301 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-05-13 | 2013-05-15 | 55,699 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-05-13 | 2013-05-15 | 4,301 | $7.09 | $30.5K | 60,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-05-13 | 2013-05-15 | 55,699 | $7.09 | $394.9K | 55,699 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2013-05-13 | 2013-05-15 | 55,699 | $22.30 | $1.24M | 4,301 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-02-15 | 2013-02-20 | 38,440 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-02-15 | 2013-02-20 | 43,749 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-02-15 | 2013-02-20 | 16,251 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-02-15 | 2013-02-20 | 16,251 | $5.46 | $88.7K | 60,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-02-15 | 2013-02-20 | 43,749 | $5.46 | $238.9K | 43,749 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2013-02-15 | 2013-02-20 | 98,440 | $22.48 | $2.21M | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-02-15 | 2013-02-20 | 38,440 | $8.99 | $345.6K | 98,440 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2013-02-09 | 2013-02-12 | 141,782 | — | $0 | 141,782 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2013-02-09 | 2013-02-12 | 8,218 | — | $0 | 8,218 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2012-04-27 | 2012-05-01 | 8,440 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2012-04-27 | 2012-05-01 | 9,751 | — | $0 | 38,440 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2012-04-27 | 2012-05-01 | 11,809 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2012-04-27 | 2012-05-01 | 30,000 | $22.95 | $688.5K | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2012-04-27 | 2012-05-01 | 11,809 | $8.99 | $106.2K | 11,809 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2012-04-27 | 2012-05-01 | 9,751 | $8.99 | $87.7K | 21,560 | SEC↗ |